|

Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia

RECRUITINGN/ASponsored by University of Pittsburgh
Actively Recruiting
PhaseN/A
SponsorUniversity of Pittsburgh
Started2024-12-03
Est. completion2026-05
Eligibility
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06643351

Summary

The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes
* Singleton Gestations
* Greater than or equal to 35 weeks gestation
* Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH)

Exclusion Criteria:

* Major fetal anomalies anticipated to require NICU admission
* Planned Cesarean delivery

Conditions4

DiabetesGestational Diabetes Mellitus in PregnancyNeonatal HypoglycemiaPregestational Diabetes Mellitus

Locations1 site

Magee-Women's Hospital of UPMC
Pittsburgh, Pennsylvania, 15213
Praveen Ramesh, M.D.412-641-4455rameshp2@upmc.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.